<DOC>
	<DOC>NCT01037855</DOC>
	<brief_summary>This is an observational study of safety and occurrence of influenza-like illness following administration of flu cell culture derived adjuvanted swine origin A (H1N1) pandemic subunit vaccine in subjects 6 months of age and older.</brief_summary>
	<brief_title>Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age ≥ 6 months Subjects will be vaccinated with Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine, independently of this study. Subjects or parent/guardian willing to provide informed consent prior to vaccination administration and complete all of the study, including followup contact • Received any prior H1N1 vaccination</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Swine Flu H1N1 vaccine</keyword>
	<keyword>Adjuvanted flu cell culture derived</keyword>
</DOC>